JP Morgan Chase
HSCS icon

JP Morgan Chase’s Heart Test Laboratories HSCS Stock Holding History

JP Morgan Chase’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$5 – 7539
2024
Q3 		$5 Hold
1
– – ﹤0.01% 7326
2024
Q2 		$5 Buy
+1
New +$8 ﹤0.01% 7246
2024
Q1 		– Hold
0
– – – 7332

Other funds holding HSCS

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's HSCS Position: Q4 2024 in Review

JP Morgan Chase sold out of Heart Test Laboratories (HSCS) in Q4 2024, closing a stake of 1 share — an estimated $5 sold.

JP Morgan Chase first reported a position in HSCS in Q2 2024 and held it in 2 quarters. The position peaked at $5 in Q3 2024. 3 funds tracked by Wall St. Rank hold HSCS as of Q4 2024.

  • JP Morgan Chase reported no remaining Heart Test Laboratories position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1 Heart Test Laboratories share in Q4 2024, an estimated $5.
  • JP Morgan Chase first reported a position in Heart Test Laboratories in Q2 2024 and held it in 2 quarters.
  • JP Morgan Chase's Heart Test Laboratories position peaked at $5 in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.